← Operating Liquidation Value Rankings
Operating Liquidation Value — Research & Development
Rankings as of 2026-03-31
Last updated: 2026-04-30 23:30 UTC
Note: Financial institutions (banks, REITs, insurance companies) use specialized accounting standards that differ from standard GAAP balance sheet presentation. Liquidation metrics may not apply and are shown as N/A where data is unavailable. See our methodology page for details.
| Rank | Ticker | Company | Value | Period |
|---|---|---|---|---|
| 1 | INCY | Incyte Corp | $2.05B | 2026-03-31 |
| — | ABSI | Absci Corp | N/A | — |
| — | BIAF | bioAffinity Technologies, Inc. | N/A | — |
| — | BUDZ | Weed, Inc. | N/A | — |
| — | CBIH | Cannabis Bioscience International Holdings, Inc. | N/A | — |
| — | CRL | Charles River Laboratories International, Inc. | N/A | — |
| — | FOXO | Foxo Technologies Inc. | N/A | — |
| — | ICLR | Icon Plc | N/A | — |
| — | IQV | Iqvia Holdings Inc. | N/A | — |
| — | ISPC | iSpecimen Inc. | N/A | — |
| — | MEDP | Medpace Holdings, Inc. | N/A | — |
| — | MXCT | Maxcyte, Inc. | N/A | — |
| — | NOTV | Inotiv, Inc. | N/A | — |
| — | NRC | Nrc Health | N/A | — |
| — | OABI | OmniAb, Inc. | N/A | — |
| — | ONMD | OneMedNet Corp | N/A | — |